Variables | GTF2I Mutation/ N = 56 (100%) | Wild type/ N = 63 (100%) | p-value |
---|---|---|---|
Gender | Â | Â | 0.855 |
 Female | 26 (46.4) | 31 (49.2) |  |
 Male | 30 (53.6) | 32 (50.8) |  |
Age | Â | Â | 0.232 |
 Mean(±SD) | 58.46(±13.32) | 55.43(±14.13) |  |
Race | Â | Â | 0.331 |
 Hispanic or latino | 3 (5.4) | 7 (11.1) |  |
 Not hispanic or latino | 53 (94.6) | 56 (88.9) |  |
MG histoty | Â | Â | 0.003 |
 Yes | 8 (14.3) | 27 (42.9) |  |
 No | 46 (82.1) | 35 (55.6) |  |
 Unknown | 2 (3.6) | 1 (1.6) |  |
Masaoka stage | Â | Â | 0.039 |
 I | 23 (41.1) | 13 (20.6) |  |
 II | 24 (42.9) | 36 (57.1) |  |
 III | 4 (7.1) | 11 (17.5) |  |
 IV | 3 (5.4) | 3 (4.8) |  |
 Unknown | 2 (3.6) | 0 (0) |  |
Pathologic type |  |  | < 0.001 |
 Type A | 14 (25.0) | 2 (3.2) |  |
 Type AB | 27 (48.2) | 8 (12.7) |  |
 Type B1 | 3 (5.4) | 11 (17.5) |  |
 Type B2 | 7 (12.5) | 24 (38.1) |  |
 Type B3 | 3 (5.4) | 9 (14.3) |  |
 Thymic carcinoma | 2 (3.6) | 9 (14.3) |  |
Radiation therapy | Â | Â | 0.004 |
 Yes | 10 (17.9) | 27 (42.9) |  |
 No | 44 (78.6) | 31 (49.2) |  |
 Unknown | 2 (3.6) | 5 (7.9) |  |
Vital status | Â | Â | 0.17 |
 Dead | 2 (3.6) | 7 (11.1) |  |
 Alive | 54 (96.4) | 56 (88.9) |  |